Does mofetil mycophenolate (MMF) delay hepatitis C recurrence in liver transplant patients?

被引：0
|
作者：
Fasola, CG [1 ]
Netto, GJ [1 ]
Jennings, LW [1 ]
Gonwa, TA [1 ]
Goldstein, RM [1 ]
Levy, MF [1 ]
Molmenti, EP [1 ]
Klintmalm, GB [1 ]
机构：
[1] Baylor Univ, Med Ctr, Transplant Serv, Dallas, TX USA
来源：
TRANSPLANTATION | 2000年 / 69卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
33
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [21] Sequential determination of pharmacokinetics (PK) and pharmacodynamics (PD) of mycophenolate mofetil (MMF) in liver transplant (LT) patients.
    Brunet, M
    Martorell, J
    Vidal, E
    Jimenez, O
    Millan, O
    Rojo, I
    Cirera, I
    Rimola, A
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 528 - 529
  • [22] Use of Mycophenolate Mofetil in Liver Transplant Patients.
    Bravo, Gomez M. A.
    Barrera, L.
    Jimenez, M.
    Rodrigo, J.
    Marin, D.
    De la Mata, M.
    Garcia, Nunez F.
    Garrido, Lopez M. A.
    Noguera, F.
    Vivaldi, Martin R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 531 - 532
  • [23] Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation
    Kornberg, A
    Küpper, B
    Tannapfel, A
    Hommann, M
    Scheele, J
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2005, 5 (01) : 107 - 115
  • [24] Can mycophenolate mofetil (MMF) be used to treat autoimmune hepatitis?
    Dakhil, Noma
    Befeler, Alex
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A801 - A801
  • [25] Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation
    Platz, KP
    Mueller, AR
    Willimski, C
    Mansoorian, B
    Berg, T
    Neuhaus, R
    Hopf, U
    Radke, C
    Neuhaus, P
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2232 - 2233
  • [26] Mycophenolate Mofetil (MMF) Pharmacokinetic Profiles and Dosage Modification in Pediatric Kidney Transplant Patients
    Chadha, V.
    VanSickle, J. S.
    Morgans, H.
    Warady, B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1143 - S1143
  • [27] Indications for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation
    Platz, KP
    Mueller, AR
    Willimski, C
    Mansoorian, B
    Berg, T
    Neuhaus, R
    Hopf, U
    Lobeck, H
    Neuhaus, P
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1468 - 1469
  • [28] Mycophenolate mofetil reduces rejection rates in hepatitis C positive liver transplant recipients.
    Baillie, GM
    Taber, DJ
    Rogers, J
    Lin, A
    Baliga, P
    Chavin, KD
    [J]. HEPATOLOGY, 2002, 36 (04) : 655A - 655A
  • [29] Pharmacokinetics of tacrolimus and mycophenolate mofetil (MMF) in live donor and deceased donor liver transplant recipients
    Jain, A.
    Venkatramanan, R.
    Kwong, T.
    Orloff, M.
    Abt, P.
    Kashyap, R.
    Tsoulfas, G.
    Mack, C.
    Batzol, P.
    Williamson, M.
    Bozorgzadeh, A.
    [J]. JOURNAL OF HEPATOLOGY, 2007, 46 : S60 - S60
  • [30] Mycophenolate Mofetil (MMF) Pharmacokinetic Profiles and Dosage Modification in Pediatric Kidney Transplant Patients
    Chadha, V.
    Vansickle, J.
    Jensen, C.
    Warady, B.
    [J]. PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1952 - 1953
12345